Vascular and Endovascular Surgery

The Division of Vascular and Endovascular Surgery at Cooper University Health Care provides highly specialized, life-saving treatment options to patients with vascular (blood vessel) disorders.

Regional Leaders in Vascular Care and Research

At Cooper University Health Care, the region’s leading academic health system, our experts educate and train the next generation of physicians, surgeons, and other health professionals. As a major center of research, we are on the forefront of pioneering new and more effective medical treatments. According to the Journal of American Medical Association, patients treated at an academic health system have up to 20% higher odds of survival versus those patients treated at a non-teaching hospital.

In the past 10 years alone, Cooper's vascular and endovascular surgeons have completed more than 25 clinical trials, published more than 500 peer-reviewed research papers, presented at more than 500 national international lectures, and educated many future vascular surgeons at our nationally renowned medical school.

Our surgeons specialize in treating vascular disease with a technique called endovascular surgery. For this type of procedure, we insert long, thin tubes called catheters through small incisions and directly into the blood vessels. We also have extensive experience performing open surgery, which requires larger incisions.

Request An Appointment

Vascular surgeons are uniquely qualified to offer both open and endovascular solutions to complex problems. Because of our skill set, we’re able to provide expert care to patients with conditions that other area centers may not treat. We offer solutions for diseases of the:

• Aorta, the vessel that carries blood from the heart to other vital organs
• Carotid arteries, which carry oxygen-rich blood to the head and brain
• Peripheral blood vessels, which transport blood in the arms, legs, hands, and feet

Why Choose Us for Vascular and Endovascular Surgery?

Our doctors, who are all fellowship-trained, are among the best vascular and endovascular surgeons in the country. U.S. News & World Report, Best Doctors in America, Castle Connelly Top Doctors, Philadelphia Magazine Top Doctors, South Jersey Magazine Top Physicians have all honored our surgeons for their excellence.

The strengths of our division include:

• High volumes of procedures: We are a high-volume center for carotid artery surgeries, aortic aneurysm repairs, and lower extremity limb salvage procedures. Performing a high number of procedures contributes to the depth of our surgeons’ experience and helps to ensure excellent outcomes for our patients.
• Devoted surgical team: Our surgeons carefully follow strict quality protocols, which improve our patients’ safety during procedures. Our advanced practice nurses and operating room technicians are completely dedicated to the care of patients with vascular diseases.
• The latest technologies: We have extensive experience with traditional open surgery and endovascular surgery. Our Hybrid OR Suite allows our surgeons to use both approaches as part of your treatment to ensure you receive the best care possible. Endovascular techniques are minimally invasive, resulting in less pain after surgery and shorter recovery times.
• Surgical training programs: The hallmark of any quality vascular department is a thriving education program. Our doctors, who are highly knowledgeable in the latest standards of care, train future generations of vascular and endovascular surgeons through surgical residency and fellowship programs. Our skilled residents and fellows provide evaluations and assist with surgical procedures. Having several doctors overseeing your treatment plan helps to ensure excellent care. Our residents present research at academic meetings and conferences every year to help move the vision of Cooper Vascular forward.
• Access to clinical trials: Our patients have access to the latest clinical trials, many of which use new technologies for treating more complex vascular disease. We are participating in more than 10 global clinical trials, leading the advancement of new methods for minimally invasive vascular surgery. We participated in the trials for several new FDA-approved devices for treating aneurysm and peripheral vascular disease (PVD).